股票/基金 实时行情 股吧

简称:千金药业 代码:600479


会计年度:2016-06-30收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合并抵销-19,043,246.01-15,358,350.15-3,684,895.86--
合计1,269,307,796.78754,232,766.97515,075,029.8140.58
其他103,333,911.9947,722,744.4455,611,167.5553.82
药品批发零售586,411,908.52491,855,044.2794,556,864.2516.12
药品生产598,605,222.28230,013,328.41368,591,893.8761.58

会计年度:2015-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合并抵消-38,032,898.28-34,319,999.38-3,712,898.90--
合计2,428,353,443.551,310,001,784.691,118,351,658.8646.05
其他151,993,711.3965,778,798.5786,214,912.8256.72
药品批发零售1,014,196,207.67836,271,171.88177,925,035.7917.54
药品生产1,300,196,422.77442,271,813.62857,924,609.1565.98

会计年度:2015-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合并抵销-25,656,834.43-24,818,335.83-838,498.60--
合计1,099,605,374.15619,074,128.24480,531,245.9143.70
其他63,635,713.1926,604,139.6737,031,573.5258.19
药品批发零售506,892,739.89421,279,592.7985,613,147.1016.89
药品生产554,733,755.50196,008,731.61358,725,023.8964.67

会计年度:2014-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合并抵销-41,736,396.46-35,102,693.79-6,633,702.67--
合计2,179,227,569.621,139,479,813.021,039,747,756.6047.71
其他92,343,087.1644,209,983.2548,133,103.9152.12
药品批发零售895,849,869.53743,181,704.96152,668,164.5717.04
药品生产1,232,771,009.39387,190,818.60845,580,190.7968.59

会计年度:2014-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合并抵销-23,133,160.22-24,752,152.861,618,992.64-7.00
合计1,017,691,686.86578,005,863.70439,685,823.1643.20
其他34,607,366.4118,233,058.2916,374,308.1247.31
药品批发零462,390,803.81387,802,649.5274,588,154.2916.13
药品生产543,826,676.86196,722,308.75347,104,368.1163.83

    3/8 转到